- Overview
- Medication Safety
- Connectivity
- EIFU & Resources
New TCI drug models
A complete solution with both Eleveld propofol and Eleveld remifentanil TCI models, promoting patient safety for all population.
Patent pending medication safety
Auto-scaling unique feature might help to minimize the potential for programming errors, especially when setting up infusions for children.
Wireless connectivity
Simplify the infusion experience through award winning IT* and connectivity solutions.
Reduce user errors to improve patient safety
- Unique colour differentiation between Propofol (white background) and Remifentanil (transparent background) to improve medication safety.
- Optional drug confirmation message when reloading a syringe.
- User-friendly interface and large display with all critical infusion data at a glance.
Limits for a tailored and safe anaesthesia infusion
- Cap rate to safety limits infusion rates in all TCI drug models.
- Patent pending auto-scaling feature. This technology automatically adjusts the suggested default settings for height and weight based on the patient’s age that is entered when using the Eleveld propofol and Eleveld remifentanil TCI model.
- Safety limit in Dexmedetomidine Hannivoort-Colin to reduce risk of hypertension and reflex bradycardia.
Simplified TCI experience
- new TCI drug models promoting patient safety for all population, eliminating the inefficiencies and the confusion of selecting the right model.
- The Eleveld Propofol and Eleveld Remifentanil models are the only TCI models able to provide PD target steering for children. They help anaesthesiologists meet IV anaesthesia requirements in a safe, timely and accurate way2.
- TCI predictive models in TIVA mode for a guided transition from TIVA to TCI.
Capability to standardize protocols hospital wide with 3,000 drug setups, 30 profiles and unlimited setups per profile in the drug library
Default and user adjustable pressure limits allow for early detection of patient access occlusion.
Large and clear display shows all key parameters at a glance.
1) Manrique-Rodríguez S, et al., 2016; 2) Sara Arenas Lopez, et al., 2016; 3) Waterson et al., 2019; 4) Ohashi K, Dalleur O, Dykes PC, Bates DW. Benefits and risks of using smart pumps to reduce medication error rates: a systematic review. Drug Saf. 2014;37(12):1011–20.
Wi-Fi enabled for automatic transmitting of infusion data through the Alaris™ Communication Engine to the hospital information systems.
- “Over the air” seamless drug library updates via BD Alaris™ Communication Engine 2.0 to enable infusion protocol standardization throughout the hospital.
- “Over the air” seamless pump event logs download (fluid, keypresses, service, events) from care areas to streamline biomedical investigation activities.
- “Over the air” accurate and encrypted patient infusion data streamed to PDMS via BD Alaris™ Communication Engine 2.0.
- Multiple Input Multiple Output (MIMO) technology for faster and robust wireless connection at greater range
- Dual antennae for enhanced signal range over vertical and horizontal plane
Capability to standardize protocols hospital wide with 3,000 drug setups, 30 profiles and unlimited setups per profile in the drug library
Default and user adjustable pressure limits allow for early detection of patient access occlusion.
Large and clear display shows all key parameters at a glance.
1) Manrique-Rodríguez S, et al., 2016; 2) Sara Arenas Lopez, et al., 2016; 3) Waterson et al., 2019; 4) Ohashi K, Dalleur O, Dykes PC, Bates DW. Benefits and risks of using smart pumps to reduce medication error rates: a systematic review. Drug Saf. 2014;37(12):1011–20.
Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.
BD-56293